| RS1168689294 |
ZNF292
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1168726198 |
RAD50
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1168737278 |
GARS1
|
Health Risk |
Pathogenic |
— |
| RS116874952 |
CLCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1168752295 |
NDUFA2
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 13 |
| RS1168752344 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1168782890 |
IDH3A
|
Health Risk |
Pathogenic |
— |
| RS1168827071 |
TK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS1168855294 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1168863456 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1168868123 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
— |
| RS116887602 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, SKIN/HAIR/EYE PIGMENTATION 5 |
| RS1168876204 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dystrophin deficiency |
| RS1168878579 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS116888866 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1168893427 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS1168899671 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS116890187 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS1168903423 |
SIX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 23, Branchiootic syndrome 3 |
| RS1168903863 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1168913250 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1168919288 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS116892396 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome, Autosomal recessive nonsyndromic hearing loss 2 |
| RS1168929877 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1168941346 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1168944129 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1168949722 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1168976920 |
GREB1L
|
Health Risk |
Conflicting classifications of pathogenicity |
GREB1L-related disorder, GREB1L-related disorder |
| RS1169002203 |
IL12RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1169005119 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1169024524 |
SMPD4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS1169032037 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1169039793 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1169048585 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1169050578 |
DGKE
|
Health Risk |
Pathogenic |
— |
| RS1169054324 |
SLC34A3
|
Health Risk |
Pathogenic |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS1169072396 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS116907814 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1169081738 |
MBD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1169086609 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS1169090943 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1169094796 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS1169095680 |
CEP55
|
Health Risk |
Pathogenic |
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome |
| RS1169100731 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS116911972 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1169162396 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS116916706 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1169181885 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1169182678 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1169190081 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast and/or ovarian cancer |
| RS1169192999 |
DNAJB11
|
Health Risk |
Likely pathogenic |
— |
| RS1169197181 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1169198442 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS116920018 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, DOCK8-related disorder |
| RS116920450 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 42, Spinocerebellar ataxia type 42 |
| RS1169211344 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1169223296 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1169227791 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS11692304 |
SLC9A4
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS1169276398 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS116928232 |
LIPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysosomal acid lipase deficiency, LIPA-related disorder |
| RS1169289 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Type 2 diabetes mellitus |
| RS1169310686 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1169311005 |
COQ2
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS1169312254 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1169314384 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1169338996 |
GALNT3
|
Health Risk |
Pathogenic |
Tumoral calcinosis, hyperphosphatemic |
| RS116934613 |
MYO9A
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO9A-related disorder, Inborn genetic diseases |
| RS1169366418 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1169371609 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1169383137 |
PFKM
|
Health Risk |
Likely pathogenic |
— |
| RS116938457 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS1169396415 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS11694 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS116940091 |
PSMG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1169402682 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS116940576 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS1169420841 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1169421274 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex 5B |
| RS1169437542 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS1169461493 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1169467662 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1169505007 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1169538148 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, ARG1-related disorder |
| RS1169539647 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1169546944 |
DOCK6
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 2, Malignant tumor of urinary bladder |
| RS1169563301 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1169567113 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS1169567839 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, CTC1-related disorder |
| RS1169577591 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS1169587141 |
RASA2
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS116959874 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS1169608420 |
PGAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1169623576 |
SETX
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS1169630255 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1169647634 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1169648392 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1169652308 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS1169667763 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS1169668668 |
NRXN1
|
Health Risk |
Pathogenic |
Pitt-Hopkins-like syndrome 2, Inborn genetic diseases |